Please use this identifier to cite or link to this item:
|Title:||Blood-based biomarkers are associated with different ischemic stroke mechanisms and enable rapid classification between cardioembolic and atherosclerosis etiologies||Authors:||Harpaz, Dorin
Seet, Raymond C. S.
Marks, Robert S.
Tok, Alfred Iing Yoong
|Keywords:||Engineering::Materials||Issue Date:||2020||Source:||Harpaz, D., Seet, R. C. S., Marks, R. S. & Tok, A. I. Y. (2020). Blood-based biomarkers are associated with different ischemic stroke mechanisms and enable rapid classification between cardioembolic and atherosclerosis etiologies. Diagnostics, 10(10), 804-. https://dx.doi.org/10.3390/diagnostics10100804||Journal:||Diagnostics||Abstract:||Stroke is a top leading cause of death, which occurs due to interference in the blood flow of the brain. Ischemic stroke (blockage) accounts for most cases (87%) and is further subtyped into cardioembolic, atherosclerosis, lacunar, other causes, and cryptogenic strokes. The main value of subtyping ischemic stroke patients is for a better therapeutic decision-making process. The current classification methods are complex and time-consuming (hours to days). Specific blood-based biomarker measurements have promising potential to improve ischemic stroke mechanism classification. Over the past decades, the hypothesis that different blood-based biomarkers are associated with different ischemic stroke mechanisms is increasingly investigated. This review presents the recent studies that investigated blood-based biomarker characteristics differentiation between ischemic stroke mechanisms. Different blood-based biomarkers are specifically discussed (b-type natriuretic peptide, d-dimer, c-reactive protein, tumor necrosis factor-α, interleukin-6, interleukin-1β, neutrophil-lymphocyte ratio, total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein and apolipoprotein A), as well as the different cut-off values that may be useful in specific classifications for cardioembolic and atherosclerosis etiologies. Lastly, the structure of a point-of-care biosensor device is presented, as a measuring tool on-site. The information presented in this review will hopefully contribute to the major efforts to improve the care for stroke patients.||URI:||https://hdl.handle.net/10356/151215||ISSN:||2075-4418||DOI:||10.3390/diagnostics10100804||Rights:||© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||MSE Journal Articles|
Files in This Item:
|Blood based biomarkers are associated with different ischemic stroke mechanims....pdf||289.38 kB||Adobe PDF||View/Open|
Updated on Oct 18, 2021
Updated on Oct 18, 2021
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.